{"id":469477,"date":"2021-04-01T07:08:14","date_gmt":"2021-04-01T11:08:14","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=469477"},"modified":"2021-04-01T07:08:14","modified_gmt":"2021-04-01T11:08:14","slug":"uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\/","title":{"rendered":"uniQure to Participate in Multiple Upcoming Industry Conferences in April"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">LEXINGTON, Mass. and AMSTERDAM, April  01, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EmX1lqr5kT6WfB1voByVUSgujs4UeZuleJHH0mLbjcQpR7ymuV4uvUg2zM8InRzZqkhXwYmpDaTRNWbU6GOOWQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">uniQure N.V.<\/a> (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced its participation in the following upcoming virtual investor and scientific conferences:<\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <strong>Virtual Guggenheim Healthcare Talks<\/strong><br \/>\n          <strong>\u2502<\/strong><br \/>\n          <strong>2021 Genomic Medicines &amp; Rare Disease, April 1, 2021<\/strong><\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">Members of uniQure\u2019s management team will participate in virtual one-on-one investor meetings throughout the day on Thursday, April 1.\n<\/li>\n<li style=\"text-align:justify\">\n              <a href=\"http:\/\/uniqure.com\/about\/management-team-matt-kapusta.php\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Matt Kapusta<\/a>, chief executive officer, will participate on a panel discussion entitled, \u201cThe Low-Hanging Fruit in Gene Therapy Might Be Hard to Reach \u2013 Challenges for Hemophilia A and B\u201d on Thursday, April 1 from 10:00 to 10:50 a.m. ET. The live webcast of the fireside chat can be accessed through the link displayed in the <a href=\"http:\/\/uniqure.com\/investors-newsroom\/events-presentations.php\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Investors &amp; Newsroom<\/a> section of the uniQure website. <\/p>\n<\/li>\n<li style=\"text-align:justify\">\n              <a href=\"http:\/\/uniqure.com\/about\/about-management-team-ricardo-dolmetsch.php\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Ricardo Dolmetsch, Ph.D<\/a>., president of research and development, will participate in a panel discussion entitled, \u201cAn Idea Whose Time has Come \u2013 Disease Modifying Therapies for Huntington\u2019s Disease\u201d later the same day from 3:00 to 3:50 p.m. ET. <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li style=\"text-align:justify\">\n          <strong>Wells Fargo Corporate Access Days, April 6-8, 2021<\/strong><\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">Members of uniQure\u2019s management team will participate in virtual one-on-one investor meetings throughout the day on Tuesday, April 6.\n<\/li>\n<\/ul>\n<\/li>\n<li>\n          <strong>Professional Patient Advocates in Life Sciences, April 13, 2021<\/strong><\/p>\n<ul type=\"disc\">\n<li>Daniel Leonard, senior director of global patient advocacy, will participate on a virtual panel discussion entitled, \u201cBuilding an Internal Patient Advocacy &amp; HR Relationship Series \u2013 Part 1: Journey to Patient Advocacy\u201d starting at 2:00 p.m. ET on Tuesday, April 13.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <strong>20<\/strong><br \/>\n          <sup><br \/>\n            <strong>th<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual Needham Virtual Healthcare Conference, April 12 &#8211; 15, 2021<\/strong><\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">Members of uniQure\u2019s management team will participate in virtual one-on-one investor meetings throughout the day on Thursday, April 15.\n<\/li>\n<li style=\"text-align:justify\">A company presentation with Matt Kapusta will take place the same day from 3:45 to 4:25 p.m. ET. The live webcast of the fireside chat can be accessed through the link displayed in the <a href=\"http:\/\/uniqure.com\/investors-newsroom\/events-presentations.php\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Investors &amp; Newsroom<\/a> section of the uniQure website.\n<\/li>\n<\/ul>\n<\/li>\n<li style=\"text-align:justify\">\n          <strong>Chardan 5<\/strong><br \/>\n          <sup><br \/>\n            <strong>th<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual Genetic Medicines Manufacturing Summit, April 26 &#8211; 27, 2021<\/strong><\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">Members of uniQure\u2019s management team will participate in virtual one-on-one investor meetings on Tuesday, April 27.\n<\/li>\n<li style=\"text-align:justify\">A fireside chat with Matt Kapusta will take place the same day from 1:45 to 2:25 p.m. ET. The live webcast of the fireside chat can be accessed through the link displayed in the <a href=\"http:\/\/uniqure.com\/investors-newsroom\/events-presentations.php\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Investors &amp; Newsroom<\/a> section of the uniQure website.\n<\/li>\n<\/ul>\n<\/li>\n<li style=\"text-align:justify\">\n          <strong>Kempen Life Sciences Conference \u2013 2021 Thematic Virtual Series \u201cCell, Gene &amp; RNA based companies,\u201d April 28, 2021<\/strong><\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">Members of uniQure\u2019s management team will participate in virtual one-on-one investor meetings on Wednesday, April 28.\n<\/li>\n<\/ul>\n<\/li>\n<li>\n          <strong>CHDI\u2019s 16<\/strong><br \/>\n          <sup><br \/>\n            <strong>th<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual Huntington\u2019s Disease Therapeutics Conference, April 27-29, 2021<\/strong><\/p>\n<ul type=\"disc\">\n<li>David Cooper, M.D., vice president of clinical research CNS, will present in the clinical stage interventional programs session on Thursday, April 29 between 10:00 a.m. and 12:30 p.m. ET. His presentation is entitled, \u201cUpdates on HD-GeneTRX-1: A Phase 1-2 Clinical Trial of CNS-Administered Gene Therapy (AMT-130) for Early-Stage HD.\u201d Following the pre-recorded presentation, Dr. Cooper will be available for live Q&amp;A.\n<\/li>\n<li>Astrid Valles-Sanchez, Ph.D., senior scientist at uniQure, will have a poster presentation entitled, \u201cLowering the Pathogenic Exon1 HTT Fragment by AAV5-miHTT Gene Therapy,\u201d during the conference dates.\n<\/li>\n<\/ul>\n<\/li>\n<li>\n          <strong>World Orphan Drug Congress, April 28, 2021<\/strong><\/p>\n<ul type=\"disc\">\n<li>Nick Li, Ph.D., M.B.A., senior director, global\/US market access lead, will participate on a panel entitled \u201cPricing &amp; Reimbursement for Rare Diseases in the United States\u201d starting at 3:00 p.m. ET on Wednesday, April 28.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p align=\"justify\">\n        <strong>About uniQure <\/strong><br \/>\n        <br \/>uniQure is delivering on the promise of gene therapy \u2013 single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LItCpBmb4F2-N0KGxZvvvUqKW4cOJqPZtDwn88D-VbXw6jGZywGkEagG9XSlT92XIfL-Z9vxzY6uQeYcrpUU12SVXyqS8iX0ciltjHdegHs=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">pipeline<\/a> of proprietary gene therapies to treat patients with hemophilia B, Huntington&#8217;s disease, Fabry disease, spinocerebellar ataxia Type 3 and other diseases.\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eW1PEn9YvC3QhmDp4dYtTMkL9dOcab21hKUWLPL0dFCo5aoTwvIHUwNgEc6Z09iHW5kuUF5dFdiDlFma0hmUdw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.uniQure.com<\/a><\/p>\n<p align=\"justify\">\n        <strong>uniQure Contacts:<\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:50%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:35%;width:35%;min-width:35%\">\n            <strong>FOR INVESTORS:<\/strong>\u00a0<\/td>\n<td style=\"max-width:31%;width:31%;min-width:31%\">\u00a0<\/td>\n<td style=\"max-width:34%;width:34%;min-width:34%\">\n            <strong>FOR MEDIA:<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<tr>\n<td>\n            <strong>Maria E. Cantor<\/strong>\n          <\/td>\n<td>\n            <strong>Chiara Russo<\/strong>\n          <\/td>\n<td>\n            <strong>Tom Malone<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td>Direct: 339-970-7536<\/td>\n<td>Direct: 617-306-9137<\/td>\n<td>Direct: 339-970-7558<\/td>\n<\/tr>\n<tr>\n<td>\n            <a href=\"mailto:m.cantor@uniQure.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">m.cantor@uniQure.com<\/a>\n          <\/td>\n<td>\n            <a href=\"mailto:c.russo@uniQure.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">c.russo@uniQure.com<\/a>\n          <\/td>\n<td>\n            <a href=\"mailto:t.malone@uniQure.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">t.malone@uniQure.com<\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwOTg2MSM0MTAxMzI3IzIwODA0MDY=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/520b8a09-2c07-47e7-af2e-4655bf13fcf8\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LEXINGTON, Mass. and AMSTERDAM, April 01, 2021 (GLOBE NEWSWIRE) &#8212; uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced its participation in the following upcoming virtual investor and scientific conferences: Virtual Guggenheim Healthcare Talks \u2502 2021 Genomic Medicines &amp; Rare Disease, April 1, 2021 Members of uniQure\u2019s management team will participate in virtual one-on-one investor meetings throughout the day on Thursday, April 1. Matt Kapusta, chief executive officer, will participate on a panel discussion entitled, \u201cThe Low-Hanging Fruit in Gene Therapy Might Be Hard to Reach \u2013 Challenges for Hemophilia A and B\u201d on Thursday, April 1 from 10:00 to 10:50 a.m. ET. The live webcast of the fireside &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;uniQure to Participate in Multiple Upcoming Industry Conferences in April&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-469477","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>uniQure to Participate in Multiple Upcoming Industry Conferences in April - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"uniQure to Participate in Multiple Upcoming Industry Conferences in April - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LEXINGTON, Mass. and AMSTERDAM, April 01, 2021 (GLOBE NEWSWIRE) &#8212; uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced its participation in the following upcoming virtual investor and scientific conferences: Virtual Guggenheim Healthcare Talks \u2502 2021 Genomic Medicines &amp; Rare Disease, April 1, 2021 Members of uniQure\u2019s management team will participate in virtual one-on-one investor meetings throughout the day on Thursday, April 1. Matt Kapusta, chief executive officer, will participate on a panel discussion entitled, \u201cThe Low-Hanging Fruit in Gene Therapy Might Be Hard to Reach \u2013 Challenges for Hemophilia A and B\u201d on Thursday, April 1 from 10:00 to 10:50 a.m. ET. The live webcast of the fireside &hellip; Continue reading &quot;uniQure to Participate in Multiple Upcoming Industry Conferences in April&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-01T11:08:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwOTg2MSM0MTAxMzI3IzIwODA0MDY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"uniQure to Participate in Multiple Upcoming Industry Conferences in April\",\"datePublished\":\"2021-04-01T11:08:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\\\/\"},\"wordCount\":647,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIwOTg2MSM0MTAxMzI3IzIwODA0MDY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\\\/\",\"name\":\"uniQure to Participate in Multiple Upcoming Industry Conferences in April - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIwOTg2MSM0MTAxMzI3IzIwODA0MDY=\",\"datePublished\":\"2021-04-01T11:08:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIwOTg2MSM0MTAxMzI3IzIwODA0MDY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIwOTg2MSM0MTAxMzI3IzIwODA0MDY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"uniQure to Participate in Multiple Upcoming Industry Conferences in April\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"uniQure to Participate in Multiple Upcoming Industry Conferences in April - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\/","og_locale":"en_US","og_type":"article","og_title":"uniQure to Participate in Multiple Upcoming Industry Conferences in April - Market Newsdesk","og_description":"LEXINGTON, Mass. and AMSTERDAM, April 01, 2021 (GLOBE NEWSWIRE) &#8212; uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced its participation in the following upcoming virtual investor and scientific conferences: Virtual Guggenheim Healthcare Talks \u2502 2021 Genomic Medicines &amp; Rare Disease, April 1, 2021 Members of uniQure\u2019s management team will participate in virtual one-on-one investor meetings throughout the day on Thursday, April 1. Matt Kapusta, chief executive officer, will participate on a panel discussion entitled, \u201cThe Low-Hanging Fruit in Gene Therapy Might Be Hard to Reach \u2013 Challenges for Hemophilia A and B\u201d on Thursday, April 1 from 10:00 to 10:50 a.m. ET. The live webcast of the fireside &hellip; Continue reading \"uniQure to Participate in Multiple Upcoming Industry Conferences in April\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-01T11:08:14+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwOTg2MSM0MTAxMzI3IzIwODA0MDY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"uniQure to Participate in Multiple Upcoming Industry Conferences in April","datePublished":"2021-04-01T11:08:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\/"},"wordCount":647,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwOTg2MSM0MTAxMzI3IzIwODA0MDY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\/","name":"uniQure to Participate in Multiple Upcoming Industry Conferences in April - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwOTg2MSM0MTAxMzI3IzIwODA0MDY=","datePublished":"2021-04-01T11:08:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwOTg2MSM0MTAxMzI3IzIwODA0MDY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwOTg2MSM0MTAxMzI3IzIwODA0MDY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-to-participate-in-multiple-upcoming-industry-conferences-in-april\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"uniQure to Participate in Multiple Upcoming Industry Conferences in April"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/469477","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=469477"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/469477\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=469477"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=469477"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=469477"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}